Morgan Stanley Axogen, Inc. Put Options Transaction History
Morgan Stanley
- $1.23 Trillion
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding AXGN
# of Institutions
126Shares Held
34.1MCall Options Held
80.7KPut Options Held
3.3K-
Arrow Mark Colorado Holdings LLC Denver, CO4.73MShares$36.2 Million0.47% of portfolio
-
Black Rock Inc. New York, NY3.23MShares$24.8 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT3.11MShares$23.8 Million2.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.41MShares$18.5 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY1.55MShares$11.9 Million0.26% of portfolio
About Axogen, Inc.
- Ticker AXGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 42,283,700
- Market Cap $324M
- Description
- AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...